Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review.
Karolina Cuerva, Dean Spirou, Adrian Cuerva, Chantal Delaquis, Jayanthi Raman
European Eating Disorders Review September 1, 2024 DOI: 10.1002/erv.3101 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic scoping review Peer reviewed |
|---|---|
| Population | Participants with eating disorders |
| Keywords | Eating disorders Psychedelic‐assisted psychotherapy Scoping review |
| Citations | 9 |
| Key findings | Preliminary evidence suggests psychedelics and psychedelic-assisted psychotherapy may reduce eating disorder symptoms, but further research with stronger designs is needed. |
Abstract
Research regarding the therapeutic application of psychedelics and psychedelic-assisted psychotherapy in the treatment of eating disorders (EDs) has begun to emerge. This systematic scoping review aimed to map and synthesise the existing evidence regarding the participant reported efficacy and perspectives concerning psychedelics in the treatment of EDs, and to identify significant research gaps. A systematic search was undertaken across several databases in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines. 1290 publications were identified, 1135 after duplicates removed, with 17 meeting full-eligibility criteria. Overall, findings suggested that most participants reported experiencing a meaningful reduction in their ED symptoms and having positive experiences or an openness to explore psychedelics as a treatment for ED symptoms, although some noted concerns of adverse effects and the importance of having psychological support to increase safety and efficacy. While preliminary research suggests psychedelics and psychedelic-assisted psychotherapy may be a viable treatment option for ED symptoms, further research with more robust research designs is required to increase confidence in its efficacy, generalisability, and safety as a therapeutic medium.
Citations in the library
Cited by 7
- Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond ACS Pharmacology & Translational Science March 7, 2025
- Exploring the role of psychedelic experiences on wellbeing and symptoms of disordered eating Psychoactives March 4, 2025
- Is there a place for psychedelics in sports practice? Acta Neuropsychiatrica 2025
- Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development. Behavioral Sciences March 6, 2026
- Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions International Journal of Eating Disorders July 2, 2026
and 2 more in the library
Cites 49
- Default Mode Network Activity and Connectivity in Psychopathology Annual Review of Clinical Psychology March 29, 2012
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder The Journal of Clinical Psychiatry November 15, 2006
- The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas Brain February 28, 2010
- 5-HT2AReceptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex Journal of Neuroscience April 15, 1997
and 44 more in the library